Home Sleep Testing Acurable has a CE-marked and FDA-cleared home sleep apnea testing device (AcuPebble SA100) already deployed in UK and Europe with plans to launch in the US, presenting a ready-made entry point for sleep clinics, telemedicine platforms, and payer-backed programs.

Ventured Growth As a venture-backed, fast-growing MedTech startup with ongoing expansion in Europe and North America, there is potential for strategic partnerships, co-development opportunities, and channel collaborations with larger medical device distributors and health systems seeking innovative at-home diagnostics.

Chronic Disease Focus Current and pipeline focus areas include COPD, asthma, and epilepsy, signaling opportunities to cross-sell monitoring solutions to pulmonology and neurology networks, sleep clinics, and integrated care programs prioritizing enabling autonomous home-based management.

Global Partnerships Existing distribution agreement in Germany and broader international expansion plans, plus collaborations with device and telemetry players, create routes for multi-market pilots, third-party integrations, and clinician-led studies to accelerate adoption.

Awarded credibility Recognitions such as Innovate UK grants, XPrize, and STEAM award enhance credibility with health systems and payers, aiding sales pitches toward procurement committees and grant-funded care models that emphasize innovation, efficiency, and cost savings.